Menu
GWAS Study

Genome-wide investigation of persistence to treatment with methotrexate in early rheumatoid arthritis.

Sysojev AÖ, Saevarsdottir S, Diaz-Gallo LM et al.

37326842 PubMed ID
GWAS Study Type
3260 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SA
Sysojev AÖ
SS
Saevarsdottir S
DL
Diaz-Gallo LM
SG
Silberberg GN
AL
Alfredsson L
KL
Klareskog L
BE
Baecklund E
BL
Björkman L
KA
Kastbom A
RS
Rantapää-Dahlqvist S
TC
Turesson C
JI
Jonsdottir I
SK
Stefansson K
FT
Frisell T
PL
Padyukov L
AJ
Askling J
WH
Westerlind H
Chapter II

Abstract

Summary of the research findings

Objectives: To investigate the influence of genetic factors on persistence with treatment of early RA with MTX monotherapy.

2,112 Swedish ancestry cases, 1,148 Swedish ancestry controls

Chapter III

Study Statistics

Key metrics and study information

3260
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.